Pitavastatin in Combination With Venetoclax for Chronic Lymphocytic Leukemia or Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Acute Myeloid Leukemia
Related studies linked through entity extraction aliases.
Efficacy of MT-401 in Patients With AML Following Stem Cell Transplant
- Status
- TERMINATED
- Phase
- PHASE2
Phase 1 First in Human Study of ZN-d5 as a Single Agent
- Status
- COMPLETED
- Phase
- PHASE1
Efficacy and Safety Evaluation of IBI188 in Combination With Demethylating Agents in Treatment of Patients With Acute Myeloid Leukemia
- Status
- SUSPENDED
- Phase
- PHASE1/PHASE2
Evaluation of Antibody Response to High-Dose Seasonal Influenza Vaccination in Patients With Myeloid Malignancy Receiving Chemotherapy and Healthy Volunteers
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
A Study of CG-806 in Patients With Relapsed or Refractory AML or Higher-Risk MDS
- Status
- TERMINATED
- Phase
- PHASE1
Venetoclax and Decitabine Assessment in Patients (≥60 - <75 Years) with Newly Diagnosed AML Eligible for Allo-SCT
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Haplo Peripheral Blood Sct In GVHD Prevention
- Status
- COMPLETED
- Phase
- PHASE1
A Study of XY0206 Tablets in Patients With Relapsed / Refractory Acute Myeloid Leukemia
- Status
- UNKNOWN
- Phase
- PHASE1
HA-1H TCR T Cell for Relapsed/Persistent Hematologic Malignancies After Allogeneic Stem Cell Transplantation
- Status
- WITHDRAWN
- Phase
- PHASE1
Role of Adrenomedullin in Leukemic Endosteal/Vascular Niches
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Observational Study for the Evaluation of Incidence of Familial AML/MDSs in Patients With Myeloid Neoplasms
- Status
- RECRUITING
- Phase
- N/A
Magrolimab, Azacitidine, and Venetoclax for the Treatment of Acute Myeloid Leukemia
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Efficacy of HAD Induction With Intensified Cytarabine in Newly-diagnosed CEBPA Double Mutated Acute Myeloid Leukemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Outcomes of Acute Myeloid Leukemia Patients
- Status
- UNKNOWN
- Phase
- N/A
Combination of Midostaurin and Gemtuzumab Ozogamicin in First-line Standard Therapy for Acute Myeloid Leukemia (MOSAIC)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Quality of Life Model for Older Patients With AML
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Decitabine+Cladribine+Cytarabine+Granulocyte Colony-stimulating Factor (D-CLAG) for Relapsed or Refractory Acute Myeloid Leukemia (AML)
- Status
- UNKNOWN
- Phase
- NA
Prevalence and Clinical Effect of IDH1/2 Mutations in Patients With Acute Myeloid Leukemia
- Status
- UNKNOWN
- Phase
- N/A
A Study of APG-115 Alone or Combined With Azacitidine in Patients With AML, CMML, or MDS
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2